GLP-1 medications are not a typical cause of dumping syndrome because they slow stomach emptying rather than speed it up
The company has a market capitalization of $263.85 million
Structurally similar to GHRP-6, it is chemically modified to be more stable and potent
Because tirzepatide is a dual agonist, clinical studies have shown it can be highly effective for weight management when combined with lifestyle changes
These pathways, in turn, facilitate cancer cell growth, survival, motility, and resistance to drugs
The goals people chase with it are telomere support, better sleep, and steadier aging of the skin, immune system, and energy